Robert Busard Brown's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 1,100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 5, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option (right to buy) | |
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 750,000 | 750,000 | - | - | Stock Option (right to buy) | |
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 15 Mar 2021 | 100,000 | 186,957 (1%) | 1% | 1.2 | 117,780 | Common Stock |
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 86,957 | 86,957 | - | - | Common Stock Warrants (right to buy) | |
Fresh Tracks Therapeutics Inc | Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 86,957 | 86,957 (0%) | 0% | - | Common Stock |